Newsroom   |   Press Releases

University of Lyon Relies on Qstream Mobile Education Solution to Improve Diagnosis and Treatment of Malignant Melanoma

New Approach Helps Dermatologists Boost Baseline Proficiency from 66% to 94% Within Weeks

BURLINGTON, MA (April 19, 2016) – Qstream, provider of mobile software that helps reinforce health care professionals’ skills in minutes a day, announced that the University of Lyon 1, an institution for research and higher education in France, is using Qstream to help dermatologists reinforce information necessary for the proper detection and treatment of malignant melanoma.

“We needed a more effective way to teach dermoscopy, which is the procedure used to detect malignant melanoma in patients. It needed to be easy, accessible and adaptable to the physicians’ activity and workload,” said Dr. Amélie Boespflug of the Cancer Research Center of Lyon. “Qstream’s adaptive algorithm and compelling game mechanics proved to be a powerfully simple way to engage busy dermatologists, and boost retention of important information for practical use on the job.”

Studies show that one-fifth of French dermatologists using dermoscopy have never received formal dermoscopic training. Using Qstream voluntarily, board-certified dermatologists and senior dermatology physicians responded to brief scenario-based challenges pushed to their mobile device every few days, while competing against their peers for points on the leader board. With an 85% average engagement rate, the University of Lyon increased dermoscopy proficiency to 94% from a baseline of 66% within a matter of weeks.

“Interval reinforcement is a proven way to increase knowledge retention,” said Mary Hallice, healthcare solutions specialist at Qstream. “In the medical field where residents must take in and retain a lot of information, a reinforcement method that’s engaging and conveniently available has tremendous benefits to both learning and on-the-job performance.”

Developed at Harvard Medical School, Qstream’s approach is scientifically proven in more than 20 clinical trials to boost retention by up to 170% and durably change clinical practice patterns to improve patient outcomes.

About Qstream
Qstream is used by 14 of the world’s top 15 pharmaceutical companies, 7 of the top 10 medical device providers, and leading medical centers around the globe to address education on hospital-acquired conditions, value-based purchasing and HCAHPS, readmissions and transitions of care, patient safety and Joint Commission continuous readiness. Available in 16 languages, the SaaS platform is easily deployed at scale in both mobile and desktop environments. To learn more, visit QstreamHealthcare.com.

Top